MedPath

北京市金药源药物研究院

Ownership
-
Established
2000-05-09
Employees
-
Market Cap
-
Website
www.bjjinyaoyuan.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Levornidazole and Sodium Chloride Injection

Product Name
左奥硝唑氯化钠注射液
Approval Number
国药准字H20247317
Approval Date
Dec 13, 2024
NMPA

Levornidazol and Sodium Chloride Injection

Product Name
左奥硝唑氯化钠注射液
Approval Number
国药准字H20210040
Approval Date
Sep 13, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.